Antares Pharma ATRS reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Antares Pharma beat estimated earnings by 100.0%, reporting an EPS of $0.02 versus an estimate of $0.01.
Revenue was up $4.60 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 3.83% increase in the share price the next day.
Here's a look at Antares Pharma's past performance:
|Quarter||Q3 2021||Q2 2021||Q1 2021||Q4 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.